Odyssey Therapeutics, Inc. (ODTX) SEC filings
ODTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026
$19.36+0.22 (+1.15%)
Close on Nov 16, 2026Market cap $930.41MP/E –Yield –
SEC filings
10 of Odyssey Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Sep 30, 2026 | Nov 4, 2026 | SEC EDGAR |
| Current report | 8-K | Nov 4, 2026 | Nov 4, 2026 | SEC EDGAR |
| Current report | 8-K | Oct 20, 2026 | Oct 20, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 8, 2026 | Sep 9, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 6, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 4, 2026 | Aug 4, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 23, 2026 | Jun 23, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 17, 2026 | Jun 17, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | Jun 17, 2026 | SEC EDGAR |
| Current report | 8-K | May 7, 2026 | May 11, 2026 | SEC EDGAR |
See a number that looks wrong?